1003-3734
2014 Issue 23
bian zhe tui jian
yang qing ;
yang qing ;
..............page:2693
..............page:2697-2703
WINDOW OF NEW DRUGS
ben kan ;
ben kan ;
..............page:2705-2706
A new anti-rheumatic drug:golimumab
ZOU Yu-zhen;DU Xiao-li;Peiking Union Medical College Hospital;Peking Union Medical College;Chinese Academy of Medical Sciences;
ZOU Yu-zhen;DU Xiao-li;Peiking Union Medical College Hospital;Peking Union Medical College;Chinese Academy of Medical Sciences;
..............page:2707-2711
Suggestion on unifying the nomenclature for rat and mouse hepatocellular vacuolation and necrosis in toxicologic pathology
JIN Yi;Shenzhen Key Laboratory of Drug Quality Standard Research;Shenzhen Institute for Drug Control;
JIN Yi;Shenzhen Key Laboratory of Drug Quality Standard Research;Shenzhen Institute for Drug Control;
..............page:2712-2715+2728
Problems and countermeasures in the data collection of medical institutions based on pharmacoeconomic evaluation perspective
REN Xiao-xiao;SUN Jie;PENG Xiao-chen;SUN Li-hua;School of Business Administration;Shenyang Pharmaceutical University;B.Braun Medical International Trading Co.;Ltd.;
REN Xiao-xiao;SUN Jie;PENG Xiao-chen;SUN Li-hua;School of Business Administration;Shenyang Pharmaceutical University;B.Braun Medical International Trading Co.;Ltd.;
..............page:2716-2720+2724
Introducing the platform for registry and publicity of drug clinical trials and analyzing the common questions in trial registry
HUANG Qin;WANG Yu-zhu;FAN Yi;LIU Xiao-yu;GAO Rong-xin;Center for Drug Evaluation of China Food and Drug Administration;
HUANG Qin;WANG Yu-zhu;FAN Yi;LIU Xiao-yu;GAO Rong-xin;Center for Drug Evaluation of China Food and Drug Administration;
..............page:2721-2724
Advance in research of the 3D model for in vitro genotoxicity tests
HAN Tian-jiao;ZHOU Chang-hui;CHANG Yan;Chinese State Institute of Pharmaceutical Industry;Shanghai Institute of Pharmaceutical Industry;National Shanghai Center for New Drug Safety Evaluation Research;
HAN Tian-jiao;ZHOU Chang-hui;CHANG Yan;Chinese State Institute of Pharmaceutical Industry;Shanghai Institute of Pharmaceutical Industry;National Shanghai Center for New Drug Safety Evaluation Research;
..............page:2725-2728
The use of polymer blends as functional coating materials for controlled drug delivery systems
LI Yun;WANG Yu-li;YANG Mei-yan;SHAN Li;GAO Chun-sheng;The Institute of Pharmacology and Toxicology;Chinese Academy of Military Medical Sciences;
LI Yun;WANG Yu-li;YANG Mei-yan;SHAN Li;GAO Chun-sheng;The Institute of Pharmacology and Toxicology;Chinese Academy of Military Medical Sciences;
..............page:2729-2733
Recent progress in research of antibody drugs for treating breast cancer
SHAO Qian;HU Chang-hua;College of Pharmaceutical Sciences of Southwest University;Chongqing Pharmaceutical Process Engineering and Quality Control Center;
SHAO Qian;HU Chang-hua;College of Pharmaceutical Sciences of Southwest University;Chongqing Pharmaceutical Process Engineering and Quality Control Center;
..............page:2734-2738
A review of posaconazole application in the treatment of invasive fungal disease
LI Nian-yi;WANG Xiao-qin;Department of Hematology;Huashan Hospital;Fudan University;
LI Nian-yi;WANG Xiao-qin;Department of Hematology;Huashan Hospital;Fudan University;
..............page:2739-2747+2757
Emerging therapies for multiple sclerosis
CHENG Rui;XU Fei-hu;ZHOU Sheng-jun;SUN Han-dong;Hangzhou Jiuyuan Gene Engineering Co.;Ltd.;
CHENG Rui;XU Fei-hu;ZHOU Sheng-jun;SUN Han-dong;Hangzhou Jiuyuan Gene Engineering Co.;Ltd.;
..............page:2748-2752
Progress in clinical application of DDP-4 inhibitors for type 2 diabetes
YANG Li;YUE Ren-song;Department of Endocrinology;Affiliated Hospital of Chengdu University of Traditional Chinese Medicine;
YANG Li;YUE Ren-song;Department of Endocrinology;Affiliated Hospital of Chengdu University of Traditional Chinese Medicine;
..............page:2753-2757
Current new technologies in e-clinical trials
CHEN Jun-chao;ZHENG Qing-shan;HUANG Ji-han;LI Lu-jin;XU Ling;YANG Juan;LIU Hong-xia;Center for Drug Clinical Research;Shanghai University of Traditional Chinese Medicine;
CHEN Jun-chao;ZHENG Qing-shan;HUANG Ji-han;LI Lu-jin;XU Ling;YANG Juan;LIU Hong-xia;Center for Drug Clinical Research;Shanghai University of Traditional Chinese Medicine;
..............page:2758-2761+2766
Cross-sectional study on occupational roles of CRA
RUAN Jun;WANG Zhi-feng;School of Public Health;Peking University;
RUAN Jun;WANG Zhi-feng;School of Public Health;Peking University;
..............page:2762-2766
Duloxetine hydrochloride enteric tablets in the treatment of major depressive disorder:a multicenter,randomized,double-blind,and positive drug parallel controlled clinical trial
HAO Xiao-nan;YANG Fu-de;KUANG Hong-wei;SHI Jian-guo;DU Bo;ZHANG Ke-rang;ZHANG Hong-yan;Key Laboratory of Mental Health;Ministry of Health;Beijing Huilongguan Hospital;West China Hospital of Sichuan University;Mental Health Center of Xi’an;Mental Health Center of Hebei Province;The First Hospital of Shanxi Medical University;
HAO Xiao-nan;YANG Fu-de;KUANG Hong-wei;SHI Jian-guo;DU Bo;ZHANG Ke-rang;ZHANG Hong-yan;Key Laboratory of Mental Health;Ministry of Health;Beijing Huilongguan Hospital;West China Hospital of Sichuan University;Mental Health Center of Xi’an;Mental Health Center of Hebei Province;The First Hospital of Shanxi Medical University;
..............page:2767-2771+2780
Efficacy and safety of iloperidone and risperidone tablets in the treatment of acute schizophrenic patients:a multi-center,randomized,double-blind,controlled clinical study
SHUANG Mei;LIU Qi;YAN Jun;KANG Lan;LIU Cui;YANG Fu-de;DU Bo;SHI Yu-zhong;XU Xiu-feng;WANG Chuan-yue;XU Guang-ming;ZHANG Hong-yan;Peking University Sixth Hospital;Key Laboratory of Mental Health;Ministry of Health;Beijing Huilongguan Hospital;Hebei Mental Health Center;Psychiatric Hospital of Henan Province;First Affiliated Hospital of Kunming Medical College;Beijing Anding Hospital of Capital University of Medical Sciences;Tianjin Anding Hospital;
SHUANG Mei;LIU Qi;YAN Jun;KANG Lan;LIU Cui;YANG Fu-de;DU Bo;SHI Yu-zhong;XU Xiu-feng;WANG Chuan-yue;XU Guang-ming;ZHANG Hong-yan;Peking University Sixth Hospital;Key Laboratory of Mental Health;Ministry of Health;Beijing Huilongguan Hospital;Hebei Mental Health Center;Psychiatric Hospital of Henan Province;First Affiliated Hospital of Kunming Medical College;Beijing Anding Hospital of Capital University of Medical Sciences;Tianjin Anding Hospital;
..............page:2772-2776
Synthesis and antioxidant activity of biphenyl curcumin analogues
WEI Xing-chuan;CAO Min-feng;DUAN Yan-fei;CAI Wei-ping;YANG Qian-cheng;DENG Ni;REN Bao-chuan;School of Chemistry and Chemical Engineering;Guangzhou University;
WEI Xing-chuan;CAO Min-feng;DUAN Yan-fei;CAI Wei-ping;YANG Qian-cheng;DENG Ni;REN Bao-chuan;School of Chemistry and Chemical Engineering;Guangzhou University;
..............page:2777-2780
Absorption and transport characteristics of the candidate drug TW918 in Caco-2 cell model
LI Qian;YANG Yu-cai;WANG Li-qiang;Huaqiao University of Molecular Medicine Research Institute;Department of Biochemical and Technology;Taiwan University;
LI Qian;YANG Yu-cai;WANG Li-qiang;Huaqiao University of Molecular Medicine Research Institute;Department of Biochemical and Technology;Taiwan University;
..............page:2781-2785+2793
Synthesis of melogliptin
ZHAO Lin;FAN Shan-shan;ZHANG Yong;College of Chemical and Pharmaceutical Engineering;Hebei University of Science and Technology;State Key Laboratory Breeding Base-Key Laboratory of Molecular Chemistry for Drug of Hebei Province;
ZHAO Lin;FAN Shan-shan;ZHANG Yong;College of Chemical and Pharmaceutical Engineering;Hebei University of Science and Technology;State Key Laboratory Breeding Base-Key Laboratory of Molecular Chemistry for Drug of Hebei Province;
..............page:2786-2789
Design,synthesis and activities of novel tamibarotene analogues containing nitrogen heterocyclic ring
LIU E;College of Chemical Engineering and Pharmacy;Jingchu University of Technology;
LIU E;College of Chemical Engineering and Pharmacy;Jingchu University of Technology;
..............page:2790-2793
Synergistic protective effects of curcumin and glucosamine on acute alcoholic liver injury in mice
LIU Li-ping;LU Qiu-jing;XUAN Liang;LU Chun-ling;GAO Lu-lu;College of Biological & Environmental Sciences;Zhejiang Wanli University;
LIU Li-ping;LU Qiu-jing;XUAN Liang;LU Chun-ling;GAO Lu-lu;College of Biological & Environmental Sciences;Zhejiang Wanli University;
..............page:2794-2797
Vaginal irritation of acetic acid thermosensitive in situ gel in mini-pigs
ZHI Rui-na;TIAN Fang;WANG Yu-zhu;HUANG Chao;XIA Min-jie;DING Xun-cheng;LI Wei-hua;State Key Lab of Family Planning Devices;Shanghai Institute of Planned Parenthood Research;School of Public Health;Fudan University;
ZHI Rui-na;TIAN Fang;WANG Yu-zhu;HUANG Chao;XIA Min-jie;DING Xun-cheng;LI Wei-hua;State Key Lab of Family Planning Devices;Shanghai Institute of Planned Parenthood Research;School of Public Health;Fudan University;
..............page:2798-2802
..............page:2802
Stability of mixed recombinant human insulin injection in simulated clinical use
SUN Xue;HUANG Yun-li;FENG Xiao-ming;LU Da-wei;National Institutes for Food and Drug Control;
SUN Xue;HUANG Yun-li;FENG Xiao-ming;LU Da-wei;National Institutes for Food and Drug Control;
..............page:2803-2805+2816
Inclusion effect of cyclodextrin and preparation of the albendazole-β-cyclodextrin inclusion complex
LIU Meng;ZHAO Jun;WANG Jian-hua;LUO Lan;MA Yun-fang;CHEN Bei;GAO Hui-jing;Department of Pharmacy;The First Affiliated Hospital of Xinjiang Medical University;
LIU Meng;ZHAO Jun;WANG Jian-hua;LUO Lan;MA Yun-fang;CHEN Bei;GAO Hui-jing;Department of Pharmacy;The First Affiliated Hospital of Xinjiang Medical University;
..............page:2806-2811
Preparation and properties of salinomycin micelles modified by tumor-penetrating peptide
MAO Xiao-li;ZHANG He;YU Yuan;LU Ying;XIE Fang-yuan;GONG Zhi-rong;SUN Zhi-guo;HE Wen-ting;ZHONG Yan-qiang;School of Traditional Chinese Medicine;Fujian Pharmaceutical University;Department of Pharmaceutics;The Second Military Medical University;
MAO Xiao-li;ZHANG He;YU Yuan;LU Ying;XIE Fang-yuan;GONG Zhi-rong;SUN Zhi-guo;HE Wen-ting;ZHONG Yan-qiang;School of Traditional Chinese Medicine;Fujian Pharmaceutical University;Department of Pharmaceutics;The Second Military Medical University;
..............page:2812-2816
Use of Monte Carlo simulation method to optimize dosing regimen of six kinds of antimicrobial agents in patients infected with P.aeruginosa
LIU Xiao-dong;YU Dan;ZHANG Zhi-jie;PANG Lu;JIAN Ling-yan;ZHAO Li-mei;Department of Pharmacy;Shenyang Hospital of China Medical University;Department of The Second Clinical Pharmacy;School of Pharmacy;China Medical University;Department of Clinical Laboratory;Shengjing Hospital of China Medical University;
LIU Xiao-dong;YU Dan;ZHANG Zhi-jie;PANG Lu;JIAN Ling-yan;ZHAO Li-mei;Department of Pharmacy;Shenyang Hospital of China Medical University;Department of The Second Clinical Pharmacy;School of Pharmacy;China Medical University;Department of Clinical Laboratory;Shengjing Hospital of China Medical University;
..............page:2817-2821+2826
Overview of the adverse reactions of iodine contrast media
GAO Ru-ya;CAO Guo-ying;Department of Pharmacy;Beijing Hospital;
GAO Ru-ya;CAO Guo-ying;Department of Pharmacy;Beijing Hospital;
..............page:2822-2826